In osteosarcoma cells, inhibition of MEK or ERK, via small molecule inhibitors or siRNA, reversed NGF-mediated downregulation of miR-92a-1-5p [106] (Fig. 2e). The gene discussed is MAP2K7; the disease is osteosarcoma.